Suchergebnisse - "Qin, Shukui"

PubPharm (172)

1

Biology and significance of alpha-fetoprotein in hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2019

von Galle, P. | Foerster, F. | Kudo, M. | +8

2

Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma : A Randomized Phase II Clinical Trial

enthalten in: The oncologist | 2019

von Zhou, A. | Bai, Y. | Song, Y. | +14

3

Lung cancer with dermatomyositis as the initial diagnosis : A case report

enthalten in: Molecular and clinical oncology | 2019

von Zhang, T. | Wu, Q. | Qin, S. | +4

4

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer : a subpopulation analysis of the JACOB trial

enthalten in: Cancer communications (London, England) | 2019

von Liu, T. | Qin, Y. | Li, J. | +10

5

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

enthalten in: Cancer communications | 2019

von Liu, T. | Qin, Y. | Li, J. | +10

6

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

enthalten in: Chinese journal of cancer | 2019

von Liu, T. | Qin, Y. | Li, J. | +10

7

Reply to C. Kersten et al and D.A. Parikh et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Qin, S. | Liu, T. | Li, J.

CommentOn: J Clin Oncol. 2018 Oct 20;36(30):3031-3039. - PMID 30199311

8

RATIONALE 301 study : tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma

enthalten in: Future oncology (London, England) | 2019

von Qin, S. | Finn, R. | Kudo, M. | +10

9

Ginsenoside Rg3 Combined with Oxaliplatin Inhibits the Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells via Downregulating PCNA and Cyclin D1

enthalten in: Biological & pharmaceutical bulletin | 2019

von Shan, K. | Wang, Y. | Hua, H. | +3

10

Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first-line therapy in patients with extensive-stage small cell lung cancer

enthalten in: Oncology letters | 2019

von Cheng, Y. | Fan, Y. | Liu, X. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]